Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Chinese Patent Office
Dow
Boehringer Ingelheim
Fish and Richardson
Cipla
Covington
Cantor Fitzgerald
UBS

Generated: June 17, 2018

DrugPatentWatch Database Preview

Orion Pharma Company Profile

« Back to Dashboard

What is the competitive landscape for ORION PHARMA, and when can generic versions of ORION PHARMA drugs launch?

ORION PHARMA has two approved drugs.

There are three US patents protecting ORION PHARMA drugs.

There are ninety-eight patent family members on ORION PHARMA drugs in forty-one countries.

Summary for Orion Pharma
International Patents:98
US Patents:3
Tradenames:7
Ingredients:2
NDAs:2

Drugs and US Patents for Orion Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Orion Pharma STALEVO 150 carbidopa; entacapone; levodopa TABLET;ORAL 021485-003 Jun 11, 2003 AB RX Yes No 6,500,867 ➤ Sign Up Y ➤ Sign Up
Orion Pharma STALEVO 125 carbidopa; entacapone; levodopa TABLET;ORAL 021485-006 Aug 29, 2008 AB RX Yes No 6,797,732 ➤ Sign Up Y ➤ Sign Up
Orion Pharma STALEVO 50 carbidopa; entacapone; levodopa TABLET;ORAL 021485-001 Jun 11, 2003 AB RX Yes Yes 6,500,867 ➤ Sign Up Y ➤ Sign Up
Orion Pharma STALEVO 50 carbidopa; entacapone; levodopa TABLET;ORAL 021485-001 Jun 11, 2003 AB RX Yes Yes 6,797,732 ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Orion Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Orion Pharma STALEVO 50 carbidopa; entacapone; levodopa TABLET;ORAL 021485-001 Jun 11, 2003 5,135,950 ➤ Sign Up
Orion Pharma STALEVO 150 carbidopa; entacapone; levodopa TABLET;ORAL 021485-003 Jun 11, 2003 5,112,861 ➤ Sign Up
Orion Pharma STALEVO 125 carbidopa; entacapone; levodopa TABLET;ORAL 021485-006 Aug 29, 2008 5,112,861 ➤ Sign Up
Orion Pharma STALEVO 200 carbidopa; entacapone; levodopa TABLET;ORAL 021485-004 Aug 2, 2007 5,135,950 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for ORION PHARMA drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Tablets 200 mg ➤ Subscribe 2007-04-11
➤ Subscribe Tablets 18.75 mg/75 mg/200 mg and 31.25 mg/125 mg/200 mg ➤ Subscribe 2009-05-19
➤ Subscribe Tablets 50 mg/200 mg/200 mg ➤ Subscribe 2008-08-28
➤ Subscribe Tablets 18.75 mg/75 mg/200 mg and 31.25 mg/125 mg/200 mg ➤ Subscribe 2009-05-19
➤ Subscribe Tablets 25/100/200 mg and 37.5/150/200 mg ➤ Subscribe 2007-06-29
➤ Subscribe Tablets 25/100/200 mg and 37.5/150/200 mg ➤ Subscribe 2007-06-29
➤ Subscribe Tablets 12.5 mg, 50 mg and 200 mg ➤ Subscribe 2008-08-05
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Express Scripts
Citi
Cerilliant
Merck
Cantor Fitzgerald
US Army
Boehringer Ingelheim
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.